José Luis Lanciego Pérez-rekin lankidetzan egindako argitalpenak (5)

2009

  1. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

2005

  1. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

    European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

  2. The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits

    Neurology, Vol. 62, Núm. 1 SUPPL. 1

2000

  1. Pathophysiology of the basal ganglia in Parkinson's disease

    Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.